Show simple item record

dc.contributor.authorBonacina, Fen_US
dc.contributor.authorCoe, Den_US
dc.contributor.authorWang, Gen_US
dc.contributor.authorLonghi, MPen_US
dc.contributor.authorBaragetti, Aen_US
dc.contributor.authorMoregola, Aen_US
dc.contributor.authorGarlaschelli, Ken_US
dc.contributor.authorUboldi, Pen_US
dc.contributor.authorPellegatta, Fen_US
dc.contributor.authorGrigore, Len_US
dc.contributor.authorDa Dalt, Len_US
dc.contributor.authorAnnoni, Aen_US
dc.contributor.authorGregori, Sen_US
dc.contributor.authorXiao, Qen_US
dc.contributor.authorCaruso, Den_US
dc.contributor.authorMitro, Nen_US
dc.contributor.authorCatapano, ALen_US
dc.contributor.authorMarelli-Berg, FMen_US
dc.contributor.authorNorata, GDen_US
dc.date.accessioned2018-08-24T15:28:27Z
dc.date.available2018-06-24en_US
dc.date.issued2018-08-06en_US
dc.date.submitted2018-08-16T08:51:36.621Z
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/43824
dc.description.abstractCholesterol homeostasis has a pivotal function in regulating immune cells. Here we show that apolipoprotein E (apoE) deficiency leads to the accumulation of cholesterol in the cell membrane of dendritic cells (DC), resulting in enhanced MHC-II-dependent antigen presentation and CD4+ T-cell activation. Results from WT and apoE KO bone marrow chimera suggest that apoE from cells of hematopoietic origin has immunomodulatory functions, regardless of the onset of hypercholesterolemia. Humans expressing apoE4 isoform (ε4/3-ε4/4) have increased circulating levels of activated T cells compared to those expressing WT apoE3 (ε3/3) or apoE2 isoform (ε2/3-ε2/2). This increase is caused by enhanced antigen-presentation by apoE4-expressing DCs, and is reversed when these DCs are incubated with serum containing WT apoE3. In summary, our study identifies myeloid-produced apoE as a key physiological modulator of DC antigen presentation function, paving the way for further explorations of apoE as a tool to improve the management of immune diseases.en_US
dc.description.sponsorship. The work of the authors is supported by: Fondazione Cariplo 2015-0524 and 2015-0564 (A.L.C.) and 2016-0852 (G.D.N.); H2020 REPROGRAM PHC-03-2015/667837-2 (A.L.C.); Telethon Foundation (GGP13002) (G.D.N.), Ministero della Salute GR-2011-02346974 (G.D.N.) and GR-2013-02355011 (F.B.); Aspire Cardiovascular Grant 2016-WI218287 (G.D.N.). F.M.M.-B. is a recipient of the British Heart Foundation Chair of Cardiovascular Immunology (CH/15/2/32064).en_US
dc.format.extent3083 - ?en_US
dc.languageengen_US
dc.language.isoenen_US
dc.relation.ispartofNat Communen_US
dc.rightsCC BY
dc.subjectAnimalsen_US
dc.subjectAntigen Presentationen_US
dc.subjectApolipoprotein E4en_US
dc.subjectApolipoproteins Een_US
dc.subjectBone Marrow Cellsen_US
dc.subjectCell Differentiationen_US
dc.subjectCell Movementen_US
dc.subjectCholesterolen_US
dc.subjectDendritic Cellsen_US
dc.subjectFatty Acidsen_US
dc.subjectFemaleen_US
dc.subjectHematopoietic Stem Cellsen_US
dc.subjectHistocompatibility Antigens Class IIen_US
dc.subjectHumansen_US
dc.subjectHypercholesterolemiaen_US
dc.subjectLymphocyte Activationen_US
dc.subjectMajor Histocompatibility Complexen_US
dc.subjectMaleen_US
dc.subjectMiceen_US
dc.subjectMice, Inbred BALB Cen_US
dc.subjectMice, Inbred C57BLen_US
dc.subjectMice, Knockouten_US
dc.subjectMyeloid Cellsen_US
dc.subjectOxysterolsen_US
dc.subjectPhospholipidsen_US
dc.subjectT-Lymphocytesen_US
dc.titleMyeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation.en_US
dc.typeArticle
dc.identifier.doi10.1038/s41467-018-05322-1en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/30082772en_US
pubs.issue1en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublished onlineen_US
pubs.volume9en_US
dcterms.dateAccepted2018-06-24en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record